Dimethylated arginine/L-arginine ratio in progression and prognosis of amyotrophic lateral sclerosis

Takeaway

  • In a postmortem study, protein arginine methyltransferase-1 (PRMT1), which facilitates arginine methylation and accounts for >90% of production of asymmetric dimethyl -arginine (ADMA), was increased in spinal motor neurons (SMNs) of patients with amyotrophic lateral sclerosis (pwALS).

  • Cerebrospinal fluid (CSF) ADMA/-arginine ratio (ARR) had a closer relationship with survival and ALS progression than functional scores at baseline exam did; ARR was a more sensitive marker of survival than forced vital capacity (%FVC), a predictor of survival.

Why this matters ?

  • ARR was identified as a highly sensitive biomarker for early stages of ALS.

  • Dysregulated ADMA and -arginine levels could be novel therapeutic targets for ALS.

International Medical Press is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by International Medical Press for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, International Medical Press recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of International Medical Press or the sponsor. International Medical Press assumes no liability for any material contained herein.